Skip to main content
. 2021 Jun 22;10(7):759. doi: 10.3390/antibiotics10070759

Figure 3.

Figure 3

Relative prevalence of non-susceptibility to the tested antimicrobial compounds of the isolates by location and sampling season. AK—amikacin, AUG—amoxicilin/clavulanic acid, ATM—aztreonam, CAZ—ceftazidime, E—erythromycin, ENF—enrofloxacin, FFC—florfenicol, IMI—imipenem, NI—nitrofurantoin, S—streptomycin, T—tetracycline, TS—sulfamethoxazole/trimethropim.